Naive T Cell Deplete Grafts for GVHD Prevention in Non-Malignant Diseases

NCT07660783 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Bone Marrow Failure
Hemoglobinopathies
Primary Immune Deficiency (PID)
Autoimmune Cytopenia
Immune Dysregulation
Hemophagocytic Lymphohistiocytosis (HLH)
Non Malignant Disorders

Interventions

BIOLOGICAL: ALLOGENEIC CD34+ ENRICHED AND CD45RA- DEPLETED PBSCs

Sponsor

Fred Hutchinson Cancer Center